The Street Is Finally Waking Up To Avadel Pharmaceuticals plc (NASDAQ: AVDL)

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Stocks Info

Avadel Pharmaceuticals plc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Drug Manufacturers – Specialty & Generic industry. The current market capitalization of Avadel Pharmaceuticals plc is $1.60B. A total of 0.65 million shares were traded on the day, compared to an average of 1.31M shares.

In the most recent transaction, MCHUGH THOMAS S bought 2,000 shares of AVDL for 14.50 per share on Jan 16 ’24. After the transaction, the Chief Financial Officer now owns 80,500 company shares. In a previous transaction on Dec 28 ’23, McCamish Mark Anthony sold 75,000 shares at 14.53 per share. AVDL shares that Director owns now total 67,025.

Among the insiders who bought shares, MCHUGH THOMAS S acquired of 2,000 shares on Aug 14 ’23 at a per-share price of $14.45. This resulted in the Chief Financial Officer holding 78,500 shares of AVDL after the transaction. In another insider transaction, McCamish Mark Anthony sold 28,975 shares at $14.93 per share on Aug 11 ’23. Company shares held by the Director now total 142,025.

Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, AVDL has a high of $19.09 and a low of $9.50.

As of this writing, AVDL has an earnings estimate of -$0.16 per share for the current quarter. EPS was calculated based on a consensus of 10.0 estimates, with a high estimate of -$0.01 per share and a lower estimate of -$0.21.

Balance Sheet Annually/Quarterly

A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. AVDL’s latest balance sheet shows that the firm has $157.22M in Cash & Short Term Investments as of fiscal 2021. There were $145.00M in debt and $21.00M in liabilities at the time. Its Book Value Per Share was $0.82, while its Total Shareholder’s Equity was $78.24M.

Analysts Opinion

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for AVDL is Buy with a score of 4.90.

Most Popular

Related Posts